LIPID-POLYMER BASED NANOPARTICLES AS A NEW GENERATION THERAPEUTIC DELIVERY PLATFORM FOR ULCERATIVE COLITIS IN VITRO/IN VIVO EVALUATION

被引:0
|
作者
Shrivastava, Birendra [1 ]
Gopaiah, K. Venkata [1 ,2 ]
Rao, G. Sudhakara [3 ]
机构
[1] Jaipur Natl Univ, Jaipur, Rajasthan, India
[2] KL Coll Pharm, Koneru Lakshamaiah Educ Fdn, Guntur, Andhra Pradesh, India
[3] Vishwa Bharathi Coll Pharmaceut Sci, Guntur, Andhra Pradesh, India
来源
PHARMACOPHORE | 2019年 / 10卷 / 04期
关键词
Novel Drug Delivery systems; Ulcerative colitis; Nanoparticles; Nanocrystalline suspensions; DRUG-DELIVERY; COLON; RELEASE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The headway of the new medication organization frameworks (NDDS) was a theme of extraordinary enthusiasm for a large number of the pharmaceutical organizations since the advancement of the new particle forced a critical consumption of capital, HR and expert experience. Irritation in the digestive tract is called IBD. Ulcerative colitis (UC) and Crohn's infection were regularly called provocative gut sickness (IBD). Lipid nanoparticles (NC) were nanocrystalline suspensions, encased by lipids that are strong at room temperature. NCs are innovative of nanoparticle transporters, notwithstanding common ones, for example, liposomes, lipid emulsions, and polymeric nanoparticles. The NCs were set up by the hot homogenization technique utilizing an assortment of extents of stearic corrosiveand triglyceride monostearate, and Budesonide was picked as the model medication for the NC readiness. Guar gum was picked as a polysaccharide for the planning of NC. The readied NCs portrayed by molecule estimate, polydispersity file, surface charge, shape and surface morphology, embodiment productivity and in vitro examinations were performed in different disintegration media. The extra chosen F6 definition was completed for in vitro discharge energy, and in vivo strength examinations. The investigation started with preformulation contemplates on the chosen medication. A few parameters were contemplated, including bright (UV) absorbance, infrared range,liquefying point, solvency studies and differential checking calorimetry (DSC). The NC arrangement process was effectively reached out on a research facility scale, demonstrated simple execution and took into consideration a reproducible scattering of NC as far as molecule estimate, embodiment productivity, stacking effectiveness, polydispersity record, and surface morphology by SEM and TEM. Discharge ponders within sight of rodent cecal substance indicated more prominent medication discharge at 24 hours of disintegration, which was very different from the medication discharged without rodent cecal substance. It was because of the corruption of guar gum within sight of rodent cecal substance. The in vitro discharge energy examined in the F6 detailing. The detailing indicated Korse-Meyer-Peppas as a best-fit model and pursues the vehicle of Super Case-II. The results of in vivo studies revealed that lipid nanoparticles were the most advisable for colon-specific drug delivery of Budesonide. It ensures that lipid nanoparticles would be therapeutically useful in the colonic region. Copyright (C) 2013 - All Rights Reserved - Pharmacophore
引用
收藏
页码:15 / 27
页数:13
相关论文
共 50 条
  • [1] Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
    Hadinoto, Kunn
    Sundaresan, Ajitha
    Cheow, Wean Sin
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) : 427 - 443
  • [2] Local anesthetic effects of bupivacaine loaded lipid-polymer hybrid nanoparticles: In vitro and in vivo evaluation
    Ma, Pengju
    Li, Ting
    Xing, Huaixin
    Wang, Suzhen
    Sun, Yingui
    Sheng, Xiugui
    Wang, Kaiguo
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 : 689 - 695
  • [3] In vitro and in vivo evaluation of novel folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery
    Zhang, Linhua
    Hu, Chunyan
    Wu, Shengjie
    Chen, Zhuo
    Fan, Fan
    Qin, Yu
    Zhu, Dunwan
    JOURNAL OF CONTROLLED RELEASE, 2017, 259 : E84 - E85
  • [4] Oral delivery of superoxide dismutase by lipid polymer hybrid nanoparticles for the treatment of ulcerative colitis
    Cui, Yaxin
    Zhu, Tianyu
    Zhang, Xueyan
    Chen, Jicong
    Sun, Fengying
    Li, Youxin
    Teng, Lesheng
    CHINESE CHEMICAL LETTERS, 2022, 33 (10) : 4617 - 4622
  • [5] Lipid-Polymer Hybrid Nanoparticles Synthesized via Lipid-Based Surface Engineering for a robust drug delivery platform
    Soomherun, Nopparuj
    Kreua-ongarjnukool, Narumol
    Niyomthai, Saowapa Thumsing
    Chumnanvej, Sorayouth
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2024, 237
  • [6] Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform
    Mandal, Bivash
    Bhattacharjee, Himanshu
    Mittal, Nivesh
    Sah, Hongkee
    Balabathula, Pavan
    Thoma, Laura A.
    Wood, George C.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2013, 9 (04) : 474 - 491
  • [7] Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform
    Zhang, Liangfang
    Chan, Juliana M.
    Gu, Frank X.
    Rhee, June-Wha
    Wang, Andrew Z.
    Radovic-Moreno, Aleksandar F.
    Alexis, Frank
    Langer, Robert
    Farokhzad, Omid C.
    ACS NANO, 2008, 2 (08) : 1696 - 1702
  • [8] Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
    Mukherjee, Anubhab
    Waters, Ariana K.
    Kalyan, Pranav
    Achrol, Achal Singh
    Kesari, Santosh
    Yenugonda, Venkata Mahidhar
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 : 1937 - 1952
  • [9] Solid lipid-polymer hybrid nanoparticles prepared with natural biomaterials: A new platform for oral delivery of lipophilic bioactives
    Wang, Taoran
    Bae, Minkyung
    Lee, Ji-Young
    Luo, Yangchao
    FOOD HYDROCOLLOIDS, 2018, 84 : 581 - 592
  • [10] Hydrocortisone-Loaded Lipid-Polymer Hybrid Nanoparticles for Controlled Topical Delivery: Formulation Design Optimization and In Vitro and In Vivo Appraisal
    Alsaidan, Omar Awad
    Elmowafy, Mohammed
    Shalaby, Khaled
    Alzarea, Sami I.
    Massoud, Diaa
    Kassem, Abdulsalam M.
    Ibrahim, Mohamed F.
    ACS OMEGA, 2023, 8 (21): : 18714 - 18725